Repros Therapeutics Inc.
RPRX
RPRX was delisted on the 31st of January, 2018.
56 hedge funds and large institutions have $12.3M invested in Repros Therapeutics Inc. in 2015 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 18 closing their positions.
65% more call options, than puts
Call options by funds: $564K | Put options by funds: $342K
3% less funds holding
Funds holding: 58 → 56 (-2)
11% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 18
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
88% less capital invested
Capital invested by funds: $104M → $12.3M (-$91.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.17M |
| 2 |
ARTA
A.R.T. Advisors
New York
|
+$524K |
| 3 |
D.E. Shaw & Co
New York
|
+$513K |
| 4 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$441K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$260K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$14.5M |
| 2 |
DCM
Destrier Capital Management
New York
|
-$2.44M |
| 3 |
Morgan Stanley
New York
|
-$2.23M |
| 4 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
-$1.84M |
| 5 |
RI
RTW Investments
New York
|
-$1.73M |
RPRX Hedge Fund Activity: Q4 2015 in Review
56 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics Inc. (RPRX) for Q4 2015, worth a combined $12.3M — down 88% from $104M a quarter earlier.
Sellers outnumbered buyers: 18 funds closed out of RPRX and 16 opened new positions — a net loss of 2 holders — while 16 trimmed existing stakes and 13 added.
The largest buyer was Millennium Management, adding an estimated $1.17M. The largest seller was Baker Bros. Advisors, exiting entirely with an estimated $14.5M sold.
- 56 institutional investors held Repros Therapeutics Inc. (RPRX) as of Q4 2015, down from 58 in Q3 2015.
- Funds reported $12.3M of Repros Therapeutics Inc. stock for Q4 2015, down 88% quarter-over-quarter.
- 16 funds opened new Repros Therapeutics Inc. positions in Q4 2015 and 18 closed out, a net change of -2 holders.
- The largest Repros Therapeutics Inc. buyer in Q4 2015 was Millennium Management, an estimated $1.17M added.
- The largest Repros Therapeutics Inc. seller in Q4 2015 was Baker Bros. Advisors, an estimated $14.5M sold.
Based on aggregated 13F filings for Q4 2015.